BioSpace News Archive

Business

New Study Suggests Zika Virus Eradication in the Americas May Become Impossible, Making the Need for a Vaccine Even More Critical

GeoVax Comments on New Study Conducted in Brazil

November 15, 2018
·
4 min read
Job Trends

Establishing Immunotherapy For Pediatric Liver Cancer

T-Cell Editor Creating the Powerful Immunotherapy Weapon

November 15, 2018
·
2 min read
Business

Oxurion and Beta Therapeutics To Develop New Heparanase Inhibitors for Treatment of dry AMD

Oxurion NV announced today that it entered into a strategic research collaboration with Beta Therapeutics Pty Ltd

November 15, 2018
·
5 min read
Business

CellGenix Appoints Dr. Udo Nirenberg as Vice President Quality Management and Member of the Management Team

CellGeni is pleased to announce the appointment of Dr. Udo Nirenberg as Vice President of Quality Management and member of the management team.

November 15, 2018
·
2 min read
MR Solutions shows new bench top CT preclinical scanner at nuclear medicine congress

MR Solutions shows new state-of-the-art bench top CT preclinical scanner with clip on PET and SPECT at nuclear medicine congress

November 15, 2018
·
2 min read
Deals

Award-Winning Book on Theranos Notes Dangers in Silicon Valley Culture

Theranos fit in with the opaque culture of Silicon Valley, which allowed it to thrive and amass a fortune without delivering anything, book argues.

November 15, 2018
·
2 min read
·
Alex Keown
Business

Boehringer Ingelheim and Epizyme Ink Collaboration Deal With $15 Million up Front and $280 Million in Biobucks

Boehringer Ingelheim and Epizyme signed a global collaboration deal to identify, develop and market cancer therapies. The deal could exceed $300 million.

November 15, 2018
·
3 min read
·
Mark Terry
Business

Cadent Takes in $40 Million to Advance Its Pipeline, Taps a New CMO

Cadent Therapeutics secured $40 million to advance its lead program, CAD-1883.The company also struck a deal with Novartis to develop NMDA modulators.

November 15, 2018
·
2 min read
·
Alex Keown
Business

One Busy Week for AbbVie: Hepatitis C, Fibroids, Alzheimer’s & Parkinson’s, and Generic Criticism

AbbVie presented additional data from two Phase III clinical trials in women with uterine fibroids. In a big news week for the company, what else is AbbVie up to?

November 15, 2018
·
4 min read
·
Mark Terry
Business

Nektar Taps New Head of Oncology Following Data Boost for NKTR-214 at SITC

It has been a busy month for San Francisco-based Nektar Therapeutics. It started with a partnership to pair its lead drug candidate with one developed by pharma giant Pfizer. On Wednesday, the company named a Genentech veteran to helm its oncology programs.

November 15, 2018
·
2 min read
·
Alex Keown